Emergent BioSolutions (EBS) Experiences Stock Surge After Unveiling Expansion Move

Following an announcement of an expansion move, Emergent BioSolutions Inc. (NYSE: EBS) stock experienced a notable surge on Thursday. EBS shares rose 46.85%, to conclude at $8.40, driven by heightened investor enthusiasm. This upward trajectory reflects a positive market reaction to Emergent’s strategic moves. Enhancing Access and Commitment Emergent BioSolutions (EBS) has demonstrated its commitment […]

Emergent BioSolutions [EBS] Downgraded to Equal-Weight at Wells Fargo

DBGI Stock

Wells Fargo took its Emergent BioSolutions [EBS] rating to the equivalent of Equal-Weight from Overweight, in a research note dated 2021-01-08. Meanwhile, Chardan Capital Markets had maintained its rating on EBS to the earlier “Buy” rating, in a research note produced for clients July 31, 2020. In addition, Guggenheim launched coverage on September 12, 2019. […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.